Cabaletta Bio Inc (NASDAQ:CABA) shares, rose in value on Friday, March 28, with the stock price down by -3.73% to the previous day’s close as strong demand from buyers drove the stock to $1.55.
Actively observing the price movement in the last trading, the stock closed the session at $1.61, falling within a range of $1.495 and $1.615. The value of beta (5-year monthly) was 2.58. Referring to stock’s 52-week performance, its high was $19.04, and the low was $1.45. On the whole, CABA has fluctuated by -14.36% over the past month.
With the market capitalization of Cabaletta Bio Inc currently standing at about $75.76 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2024-Nov-13.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CABA’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of CABA currently trading nearly -11.23% and -26.47% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 34.37, while the 7-day volatility ratio is showing 8.36% which for the 30-day chart, stands at 8.93%. Furthermore, Cabaletta Bio Inc (CABA)’s beta value is 2.39, and its average true range (ATR) is 0.16.
A comparison of Cabaletta Bio Inc (CABA) with its peers suggests the former has fared considerably weaker in the market. CABA showed an intraday change of -3.73% in last session, and over the past year, it shrunk by -90.86%%.
Data on historical trading for Cabaletta Bio Inc (NASDAQ:CABA) indicates that the trading volumes over the past 10 days have averaged 0.85 and over the past 3 months, they’ve averaged 1.20 million. According to company’s latest data on outstanding shares, there are 48.85 million shares outstanding.
Nearly 9.03% of Cabaletta Bio Inc’s shares belong to company insiders and institutional investors own 74.15% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 6.23 million shares as on 2025-03-14, resulting in a short ratio of 5.3. According to the data, the short interest in Cabaletta Bio Inc (CABA) stood at 1317.00 of shares outstanding as of 2025-03-14; the number of short shares registered in 2025-02-14 reached 6.2 million. The stock has fallen by -31.72% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CABA stock heading into the next quarter.
